Add To Favorites Mumbai: Sun Pharma, including its subsidiary companies, announced today that one of its wholly-owned subsidiaries has entered into a licensing agreement with Pharmazz Inc., a biopharmaceutical firm based in the United States. The purpose of this agreement is to facilitate the commercialization of an innovative drug called Tyvalzi™ (Sovateltide) in the Indian …
Add To Favorites New Delhi: Domestic drug makers Sun Pharma and Alembic are recalling products in the US market due to manufacturing issues, according to the US Food and Drug Administration (USFDA). As per the US health regulator’s latest Enforcement Report, the Mumbai-based drug major is recalling 12,336 bottles of Buprenorphine Sublingual tablets, used for …
Sun Pharma, Alembic recall drugs in US market, Health News, ET HealthWorld Read More »
Add To Favorites New Delhi: Sun Pharmaceutical Industries on Tuesday said it has entered into a licensing pact with Philogen SpA to commercialise under-development skin cancer drug in Europe, Australia and New Zealand. The companies have come together to commercialise Philogen‘s speciality product Nidlegy, an anti-cancer biopharmaceutical currently in Phase III clinical trials, Sun Pharma …
Add To Favorites FILE – The anti-viral drug Paxlovid is displayed in New York, Monday, Aug. 1, 2022. Pfizer received full approval for the COVID-19 medication on Thursday, May 25, 2023, winning the U.S. Food and Drug Administration’s full endorsement for a drug that has been the go-to treatment against the virus for more than …
USFDA approves world’s first oral antiviral for Covid-19, Health News, ET HealthWorld Read More »
Add To Favorites The company is investigating the matter with utmost priority, it informed in a regulatory filing. The appropriate containment and remediation actions are being taken in a controlled manner to address the incident, it added. Updated On May 25, 2023 at 02:47 PM IST New Delhi: Drug firm Granules India on Thursday reported …
Add To Favorites New Delhi: Drug major Sun Pharmaceutical Industries is recalling pre-filled syringes of a drug, used to treat infertility in women, in the US market due to a manufacturing issue, according to the US health regulator. In its latest Enforcement Report, the US Food and Drug Administration (USFDA) noted that the Mumbai-based drug …
Add To Favorites New Delhi: The U.S. Food and Drug Administration (FDA) has asked India’s Sun Pharmaceutical Industries Ltd to halt tests on one dose of an experimental dermatological drug due to the potential of blood clots, the company said on Tuesday. The FDA has also said that patients with alopecia areata, an autoimmune condition …
US FDA halts Sun Pharma’s trials on dermatological drug, Health News, ET HealthWorld Read More »
Add To Favorites New Delhi: Shares of Sun Pharma fell 3 per cent to Rs 960 on the BSE in Monday’s trade after the drugmaker temporarily halted production at its Mohali facility to implement corrective measures in line with the US Food and Drug Administration (US FDA) guidance. “We now wish to inform you that …
